| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Common Stock | Options Exercise | $0 | +10,392 | +138% | $0.000000 | 17,902 | 18 Jan 2022 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +3,911 | +22% | $0.000000 | 21,813 | 18 Jan 2022 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +3,810 | +17% | $0.000000 | 25,623 | 18 Jan 2022 | Direct | |
| transaction | EQIX | Common Stock | Options Exercise | $0 | +3,710 | +14% | $0.000000 | 29,333 | 18 Jan 2022 | Direct | |
| transaction | EQIX | Common Stock | Sale | $293,983 | -400 | -1.4% | $734.96 | 28,933 | 19 Jan 2022 | Direct | F1, F2 |
| transaction | EQIX | Common Stock | Sale | $1,911,060 | -2,596 | -9% | $736.16 | 26,337 | 19 Jan 2022 | Direct | F1, F3 |
| transaction | EQIX | Common Stock | Sale | $1,066,535 | -1,447 | -5.5% | $737.07 | 24,890 | 19 Jan 2022 | Direct | F1, F4 |
| transaction | EQIX | Common Stock | Sale | $812,119 | -1,100 | -4.4% | $738.29 | 23,790 | 19 Jan 2022 | Direct | F1, F5 |
| transaction | EQIX | Common Stock | Sale | $635,696 | -860 | -3.6% | $739.18 | 22,930 | 19 Jan 2022 | Direct | F1, F6 |
| transaction | EQIX | Common Stock | Sale | $225,145 | -304 | -1.3% | $740.61 | 22,626 | 19 Jan 2022 | Direct | F1, F7 |
| transaction | EQIX | Common Stock | Sale | $296,781 | -400 | -1.8% | $741.95 | 22,226 | 19 Jan 2022 | Direct | F1, F8 |
| transaction | EQIX | Common Stock | Sale | $222,940 | -300 | -1.3% | $743.13 | 21,926 | 19 Jan 2022 | Direct | F1, F9 |
| transaction | EQIX | Common Stock | Sale | $446,619 | -600 | -2.7% | $744.36 | 21,326 | 19 Jan 2022 | Direct | F1, F10 |
| transaction | EQIX | Common Stock | Sale | $149,008 | -200 | -0.94% | $745.04 | 21,126 | 19 Jan 2022 | Direct | F1, F11 |
| transaction | EQIX | Common Stock | Sale | $448,876 | -600 | -2.8% | $748.13 | 20,526 | 19 Jan 2022 | Direct | F1, F12 |
| transaction | EQIX | Common Stock | Sale | $278,827 | -372 | -1.8% | $749.53 | 20,154 | 19 Jan 2022 | Direct | F1, F13 |
| transaction | EQIX | Common Stock | Sale | $300,273 | -400 | -2% | $750.68 | 19,754 | 19 Jan 2022 | Direct | F1, F14 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EQIX | Restricted Stock Unit | Award | $0 | +10,392 | $0.000000 | 10,392 | 18 Jan 2022 | Common Stock | 10,392 | $0.000000 | Direct | F15, F16 | |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -10,392 | -100% | $0.000000* | 0 | 18 Jan 2022 | Common Stock | 10,392 | $0.000000 | Direct | F15, F16 |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -3,911 | -100% | $0.000000* | 0 | 18 Jan 2022 | Common Stock | 3,911 | $0.000000 | Direct | F16, F17 |
| transaction | EQIX | Restricted Stock Unit | Options Exercise | $0 | -3,810 | -50% | $0.000000 | 3,810 | 18 Jan 2022 | Common Stock | 3,810 | $0.000000 | Direct | F16, F18 |
| transaction | EQIX | Restricted Stock Units | Options Exercise | $0 | -3,710 | -33% | $0.000000 | 7,418 | 18 Jan 2022 | Common Stock | 3,710 | $0.000000 | Direct | F16, F19 |
| Id | Content |
|---|---|
| F1 | Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $734.52 to $735.35, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 14 to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $735.63 to $736.56 inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $736.64 to $737.46 inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $737.72 to $738.55 inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $738.80 to $739.52 inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $740.25 to $740.72 inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $741.79 to $742.11 inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $742.80 to $743.80 inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $743.84 to $744.57 inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $745.02 to $745.07 inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $747.75 to $748.33 inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $749.19 to $749.82 inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.39 to $751.02 inclusive. |
| F15 | On February 22, 2019, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2019 to December 31, 2021. The Compensation Committee certified that the payout for this award would be 177.14% (out of a possible 200%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index. |
| F16 | Restricted stock unit award expires upon reporting person's termination of service. |
| F17 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2020 and an additional 33.33% of the RSUs will each vest on January 15, 2021 and January 15, 2022. |
| F18 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2021 and an additional 33.33% of the RSUs will each vest on January 15, 2022 and January 15, 2023. |
| F19 | Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2022 and an additional 33.33% of the RSUs will each vest on January 15, 2023 and January 15, 2024. |